{"name": "AiCuris",
 "permalink": "aicuris",
 "crunchbase_url": "http://www.crunchbase.com/company/aicuris",
 "homepage_url": "http://www.aicuris.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "Infectious Diseas BioPharma Company",
 "created_at": "Sat Apr 24 03:44:12 UTC 2010",
 "updated_at": "Sat Apr 24 03:44:11 UTC 2010",
 "overview": "\u003Cp\u003EAiCuris is a clinical-stage biopharmaceutical company focused on resistance breaking antiviral and antibacterial therapeutics targeting Human Cytomegalovirus, Herpes simplex, HIV, Hepatitis B and C and multi-resistant bacteria.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       54],
      "assets/images/resized/0008/4789/84789v1-max-150x150.png"],
     [[250,
       91],
      "assets/images/resized/0008/4789/84789v1-max-250x250.png"],
     [[254,
       93],
      "assets/images/resized/0008/4789/84789v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$74.8M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://onbiovc.com/aicuris-gmbh-series-b-748m/",
    "source_description": "AiCuris, GmbH: Series B $74.8M",
    "raised_amount": 74800000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 23,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Espirito Santo Ventures",
         "permalink": "espirito-santo-ventures",
         "image":
          {"available_sizes":
            [[[150,
               69],
              "assets/images/resized/0003/2811/32811v1-max-150x150.png"],
             [[200,
               92],
              "assets/images/resized/0003/2811/32811v1-max-250x250.png"],
             [[200,
               92],
              "assets/images/resized/0003/2811/32811v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Bayer Healthcare",
         "permalink": "bayer-healthcare",
         "image":
          {"available_sizes":
            [[[150,
               12],
              "assets/images/resized/0026/8668/268668v1-max-150x150.png"],
             [[250,
               20],
              "assets/images/resized/0026/8668/268668v1-max-250x250.png"],
             [[450,
               36],
              "assets/images/resized/0026/8668/268668v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Headquarters",
    "address1": "Friedrich-Ebert-Str. 475",
    "address2": "Building 302",
    "zip_code": "Wuppertal",
    "city": "D-42117 ",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}